PT2173710E - Nova forma cristalina - Google Patents

Nova forma cristalina Download PDF

Info

Publication number
PT2173710E
PT2173710E PT87886545T PT08788654T PT2173710E PT 2173710 E PT2173710 E PT 2173710E PT 87886545 T PT87886545 T PT 87886545T PT 08788654 T PT08788654 T PT 08788654T PT 2173710 E PT2173710 E PT 2173710E
Authority
PT
Portugal
Prior art keywords
crystalline form
novel crystalline
novel
crystalline
Prior art date
Application number
PT87886545T
Other languages
English (en)
Inventor
Axel Becker
Original Assignee
Generics Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38543380&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2173710(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Generics Uk Ltd filed Critical Generics Uk Ltd
Publication of PT2173710E publication Critical patent/PT2173710E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Liquid Crystal Substances (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)
PT87886545T 2007-08-10 2008-08-08 Nova forma cristalina PT2173710E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0715626.8A GB0715626D0 (en) 2007-08-10 2007-08-10 Crystalline form of zofenopril calcium

Publications (1)

Publication Number Publication Date
PT2173710E true PT2173710E (pt) 2016-01-12

Family

ID=38543380

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87886545T PT2173710E (pt) 2007-08-10 2008-08-08 Nova forma cristalina

Country Status (14)

Country Link
US (1) US8710241B2 (pt)
EP (1) EP2173710B1 (pt)
JP (1) JP5455905B2 (pt)
CN (1) CN101815702B (pt)
AU (1) AU2008288295B2 (pt)
CA (1) CA2694835C (pt)
DK (1) DK2173710T3 (pt)
ES (1) ES2556227T3 (pt)
GB (1) GB0715626D0 (pt)
HR (1) HRP20151166T1 (pt)
HU (1) HUE028205T2 (pt)
PL (1) PL2173710T3 (pt)
PT (1) PT2173710E (pt)
WO (1) WO2009022168A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8853421B2 (en) 2008-02-27 2014-10-07 Generics [Uk] Limited Crystalline forms of zofenopril calcium
CN101981004B (zh) * 2008-02-27 2014-09-17 基因里克斯(英国)有限公司 晶体形式
SI23949A (sl) 2011-12-19 2013-06-28 Silverstone Pharma Nove kristalne soli zofenoprila, postopek za njihovo dobivanje in njihova uporaba v terapiji
CN104138359B (zh) * 2013-05-06 2016-03-02 扬子江药业集团上海海尼药业有限公司 佐芬普利钙片的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1144930A (en) 1978-08-11 1983-04-19 Miguel A. Ondetti Mercaptoacyl derivatives of substituted prolines
US4316906A (en) * 1978-08-11 1982-02-23 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of substituted prolines
IT1301993B1 (it) 1998-08-04 2000-07-20 Menarini Ricerche Spa Processo per la preparazione di zofenopril sale di calcio.
WO2005070462A2 (en) * 2004-01-12 2005-08-04 Sepracor, Inc. Compositions comprising (s)-amlodipine and an angiotensin receptor blocker and methods of their use
ES2560502T3 (es) 2005-07-01 2016-02-19 Generics [Uk] Limited Zofenopril calcio en forma de polimorfo C
DK2041083T3 (en) 2006-05-26 2015-01-26 Generics Uk Ltd Methods for the preparation of zofenopril calcium
CN101012192A (zh) * 2007-01-30 2007-08-08 广东邦民制药厂有限公司 一种佐芬普利钙的制备方法

Also Published As

Publication number Publication date
CA2694835C (en) 2013-01-29
JP5455905B2 (ja) 2014-03-26
HUE028205T2 (en) 2016-12-28
EP2173710B1 (en) 2015-09-16
CN101815702A (zh) 2010-08-25
DK2173710T3 (en) 2015-11-23
ES2556227T3 (es) 2016-01-14
WO2009022168A1 (en) 2009-02-19
JP2010535753A (ja) 2010-11-25
US20110098334A1 (en) 2011-04-28
EP2173710A1 (en) 2010-04-14
HRP20151166T1 (hr) 2016-01-01
CA2694835A1 (en) 2009-02-19
US8710241B2 (en) 2014-04-29
PL2173710T3 (pl) 2016-02-29
AU2008288295A1 (en) 2009-02-19
AU2008288295B2 (en) 2013-06-06
GB0715626D0 (en) 2007-09-19
CN101815702B (zh) 2012-10-24

Similar Documents

Publication Publication Date Title
GB0819182D0 (en) Crystalline forms
EP2152081A4 (en) NEW CONNECTIONS
EP2146745A4 (en) NOVEL CONNECTIONS
GB0705882D0 (en) Novel compounds
GB0706630D0 (en) Novel compounds
GB0705803D0 (en) Novel compounds
EP2128124A4 (en) NEW HEXATRIENE- -CARBONYL COMPOUND
PT2173710E (pt) Nova forma cristalina
ZA200806859B (en) Novel crystalline compounds
IL195092A0 (en) Crystalline form of (s)-1-phenylethylammonium (r)-diphenyl-methanesulphinyl-acetate
GB0706772D0 (en) Novel compound
HU0800755D0 (en) Novel crystalline forms
GB0703973D0 (en) Novel compounds
IL213288A0 (en) Crystalline forms
GB0817164D0 (en) Crystalline forms
GB0717334D0 (en) Novel compound
GB0717338D0 (en) Novel compound
GB0720917D0 (en) Novel compound
GB0717336D0 (en) Novel compound
GB0717335D0 (en) Novel compound
GB0710864D0 (en) Novel compound
GB0717332D0 (en) Novel compound
GB0717333D0 (en) Novel compound
GB0717468D0 (en) Novel compound
GB0704766D0 (en) Novel compounds